Abstract submission is now closed.

Many thanks to all who submitted abstracts.

Abstract notifications will be made in April. Please note that confirmed presenters are required to register for the conference, at least for the day of their presentation. The attended poster session will be on Tuesday, 11 July 2017.

Professionals and trainees in the field of prenatal diagnosis and therapy were encouraged to submit abstracts to present their work at the 21st International Conference in San Diego. Abstracts were accepted for oral presentations and posters. Suggested topics are listed on this page, but other relevant topics were welcome.

If you are not on our e-mail list, but would like to receive updates on the conference, please create an account. (Membership is optional.)
Abstracts were encouraged in the following areas:
  • Cytogenetics and Molecular Genetics
  • Epigenetics and development
  • Fetal and placental development and pathology
  • Fetal imaging: Ultrasound and Magnetic Resonance Imaging
  • Fetal medical and surgical therapy
  • Global issues in prenatal diagnosis and screening
  • Maternal serum/NT screening for aneuploidy
  • Noninvasive prenatal diagnosis and screening
  • Pre-implantation genetic diagnosis and screening
  • Prenatal diagnosis of single gene disorders / inborn errors of metabolism
  • Prenatal diagnostic procedures
  • Prenatal genetic counseling
  • Prenatal prediction of adverse pregnancy outcomes (e.g pre-eclampisa / preterm labour / growth restriction and stillbirth)
  • Psychosocial, legal and ethical issues in prenatal screening and diagnosis
  • Reproductive genomics, metabolomics and proteomics
  • Screening for single gene disorders
  • Teratogens and Fetal infection
  • Twins
  • Other
See links to abstracts from previous years on the Downloads page.